| "A lot of founders mix up raising money with making money.” This quote, which Career Karma founder Ruben Harris mentioned off-hand on a phone call with me, has been on my mind for months. In fact, raising money can cost you money, in the form of that sweet, sweet ownership and equity. That's why Clearbanc, a startup I have covered for years, has always had a compelling pitch. The company, co-founded by Michele Romanow and Andrew D'Souza, positions itself as an alternative equity-free capital solution for early-stage founders. Flexing its "20-minute term sheet" the startup uses an algorithm to shift through a startup's data, and if it has positive ad spend and positive unit economics, they make an investment worth anything from $10,000 to over $10 million. It makes money through a revenue-share agreement versus an equity stake. "While we've invested in over 4,000 businesses using this model, we've also turned away over 50,000 who weren't at this scale or level of repeatability," D'Souza tells TechCrunch. So, the startup told me this week that they have raised $10 million to create a new product: ClearAngel. The startup is trying to back anyone with an online business that has early revenue, but pre-broad traction. Clearbanc wants to replace friends and family money, a concept that D'Souza says is "quite elitist," with its own version of an angel check, while also offering founder services such as supply chain analysis, introductions to networks and competitive landscape analysis. The startup just needs to make around $1,000 in monthly revenue to qualify for cash. In return for an investment between $10,000 to $50,000, founders have to pay up to 2% of their revenue over four years. Clearbanc's repayment works for some startups, but for others, a traditional bank loan could work better. Its biggest hurdle, I'd argue, is that if a startup has great revenue already, you might not want to take a revenue-share agreement loan. As for if a startup takes ClearAngel capital and doesn't make the minimum revenue? “Then the ClearAngel product isn't working," he said. "There are bound to be some companies who still can't make it, that's the risk we take." Alternative capital has pros and cons, just like venture capital has pros and cons. If the end goal is to become a billion-dollar business, what's the best route to do that? Is taking a revenue-share agreement going to hurt your chances as a pre-seed startup trying to raise capital? Does YC care at all? Those are some of my biggest questions, and we'll explore all (and more!) in my alternative financing panel next week for TC Sessions: Justice. It costs $5 to attend the entire conference, and speakers include Backstage Capital's Arlan Hamilton and Congresswoman Barbara Lee. As always, you can find me @nmasc_ on Twitter or e-mail me at natasha.m@techcrunch.com. | 
Post a Comment